These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1365474)

  • 1. Four commonly prescribed non-steroidal anti-inflammatory drugs for rheumatoid arthritis.
    Huskisson EC
    Eur J Rheumatol Inflamm; 1991; 11(2):8-12. PubMed ID: 1365474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical comparison of two leading non-steroidal anti-inflammatory drugs.
    Huskisson EC; Scott DL
    Eur J Rheumatol Inflamm; 1991; 11(2):4-7. PubMed ID: 1365472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kidney function in therapy with non-steroidal antiphlogistic drugs. A double-blind cross-over study with diclofenac, indomethacin and piroxicam].
    Lang B; Hauk P; Meske S; Keller E; Peter HH
    Z Rheumatol; 1991; 50(6):366-70. PubMed ID: 1796656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
    Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of naproxen and piroxicam in the treatment of rheumatoid arthritis: a double-blind, crossover study.
    Chlud K; Pangerl S
    Pharmatherapeutica; 1985; 4(2):113-21. PubMed ID: 3903778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter comparison of naproxen and indomethacin in rheumatoid arthritis.
    Castles JJ; Moore TL; Vaughan JH; Bolzan JA; Lee M; Lidsky MD; Caldwell JR; Ehrlich GE; Sharp JT; Kaye R
    Arch Intern Med; 1978 Mar; 138(3):362-6. PubMed ID: 343743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis.
    Domljan Z; Durrigl T
    Eur J Rheumatol Inflamm; 1983; 6(3):291-6. PubMed ID: 6391934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind randomised controlled trial of droxicam versus indomethacin in rheumatoid arthritis.
    Sánchez Andrada S; Rodríguez Valverde V
    Eur J Rheumatol Inflamm; 1991; 11(4):15-20. PubMed ID: 1365485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two double blind trials of diclofenac sodium with aspirin and with naproxen in the treatment of patients with rheumatoid arthritis.
    Kolodny AL
    J Rheumatol; 1988 Aug; 15(8):1205-11. PubMed ID: 3054094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diclofenac/misoprostol: the European clinical experience.
    McKenna F
    J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The postoperative analgesic efficacy and safety of piroxicam (FDDF) and naproxen sodium.
    Selçuk E; Gomel M; Apaydin S; Köse T; Tuglular I
    Int J Clin Pharmacol Res; 1998; 18(1):21-9. PubMed ID: 9604731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drugs for perioperative pain control.
    Burgess FW; Browning RA
    Med Health R I; 2001 Oct; 84(10):327-8. PubMed ID: 11693050
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative double-blind study of droxicam (new NSAID) versus indomethacin in rheumatoid arthritis.
    Rodríguez-de-la-Serna A; Geli-Ferrer C; Diaz-López C; Sánchez-García J
    Eur J Rheumatol Inflamm; 1991; 11(4):35-44. PubMed ID: 1365489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of piroxicam with naproxen in rheumatoid arthritis: a double-blind, cross-over, multicentre study.
    Sydnes OA
    Eur J Rheumatol Inflamm; 1981; 4(3):318-22. PubMed ID: 6242953
    [No Abstract]   [Full Text] [Related]  

  • 17. Rofecoxib in rheumatoid arthritis: new indication. No better that other NSAIDS.
    Prescrire Int; 2003 Jun; 12(65):89-90. PubMed ID: 12825570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, comparative study of diflunisal and naproxen in the treatment of rheumatoid arthritis.
    Devereaux MD; Douglas WA
    Eur J Rheumatol Inflamm; 1983; 6(3):274-8. PubMed ID: 6391932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
    Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
    Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm treatment with nonsteroidal antiinflammatory drugs in rheumatoid arthritis: a prospective drug survival study.
    Wijnands M; van Riel P; van 't Hof M; Gribnau F; van de Putte L
    J Rheumatol; 1991 Feb; 18(2):184-7. PubMed ID: 2023212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.